Jazz Pharmaceuticals gets a heavy border in today’s Sector Leaders charts (see Page B1) because it’s near a 191.11 buy point. But don’t let that make you give fellow drugmaker Gilead Sciences short shrift, because it’s back above its 10-week moving average as it works on a flat base with a 123.47 buy point. Shares of (GILD) gapped up Wednesday on strong earnings. It closed near lows after early strength, but shares still rose 2%.